Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01271855 · ClinicalTrials.gov registry record · Phase 4

Assessing Maternal Post-partum Pain With Suppositories

A Phase 4 study, sponsored by Loyola University.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target

NCT01271855: Completed Phase 4 study, sponsored by Loyola University.

NCT01271855 is a Phase 4 study that has completed, run by Loyola University. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01271855, a Phase 4 study, has completed, sponsored by Loyola University.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

This trial will evaluate whether the routine use of belladonna/opium (B\&O) suppositories improve patients' self-reported pain control in the first 24-hours after delivery.

Primary Outcome

The primary outcome is pain measured at 24-hours after delivery. Patients will be asked to report a Visual Analog Scale (VAS) pain score at 24-hours after delivery. This scale ranges from 0 to 10 (0=no pain and 10=worst pain).

Interventions

  • DRUG Glycerin Suppository
  • DRUG Belladonna and opioid suppository

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2009-07-22
Est. Completion 2011-09-29
Phase Phase 4
Loyola University

92 total trials

What the finished NCT01271855 record still lists

NCT01271855 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 2 interventions - of which Glycerin Suppository is the first listed.

NCT01271855 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01271855 about?

NCT01271855 is a clinical study titled "Assessing Maternal Post-partum Pain With Suppositories". This trial will evaluate whether the routine use of belladonna/opium (B\&O) suppositories improve patients' self-reported pain control in the first 24-hours after delivery.

What is the current status of trial NCT01271855?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2009-07-22. Estimated completion is 2011-09-29.

What interventions are being tested in trial NCT01271855?

The interventions under investigation include: Glycerin Suppository (DRUG), Belladonna and opioid suppository (DRUG).

Who is sponsoring clinical trial NCT01271855?

This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01271855's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01271855, the US trial registry maintained by the National Library of Medicine. NCT01271855 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.